Does REVUMENIB Cause Product dose omission issue? 40 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 40 reports of Product dose omission issue have been filed in association with REVUMENIB (Revuforj). This represents 10.8% of all adverse event reports for REVUMENIB.
40
Reports of Product dose omission issue with REVUMENIB
10.8%
of all REVUMENIB reports
2
Deaths
17
Hospitalizations
How Dangerous Is Product dose omission issue From REVUMENIB?
Of the 40 reports, 2 (5.0%) resulted in death, 17 (42.5%) required hospitalization.
Is Product dose omission issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for REVUMENIB. However, 40 reports have been filed with the FAERS database.
What Other Side Effects Does REVUMENIB Cause?
Off label use (57)
Platelet count decreased (50)
Nausea (49)
Death (38)
Vomiting (26)
Fatigue (24)
Pyrexia (22)
Differentiation syndrome (16)
Haemoglobin decreased (16)
White blood cell count decreased (16)
What Other Drugs Cause Product dose omission issue?
DUPILUMAB (18,189)
USTEKINUMAB (9,405)
GUSELKUMAB (9,267)
LENALIDOMIDE (8,145)
MEPOLIZUMAB (5,873)
TOFACITINIB (5,646)
VOXELOTOR (5,122)
BELIMUMAB (4,671)
SECUKINUMAB (4,572)
APREMILAST (4,460)
Which REVUMENIB Alternatives Have Lower Product dose omission issue Risk?
REVUMENIB vs REYATAZ
REVUMENIB vs REZAFUNGIN
REVUMENIB vs RIBASPHERE
REVUMENIB vs RIBAVIRIN
REVUMENIB vs RIBOCICLIB